Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quelling of Excitotoxicity in Acute Stroke With Ketamine

NCT03223220 is registered in ClinicalTrials.gov with Lower Merion Neurology Research Foundation as lead sponsor.

NCT NCT03223220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03223220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quelling of Excitotoxicity in Acute Stroke With Ketamine
Lead sponsor
Lower Merion Neurology Research Foundation
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
December 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke